Answers are grounded in this paper and cite their sources.
The introduction of the Qdenga® dengue vaccine presents both opportunities and challenges. Debate regarding efficacy, safety, and potential risks for dengue-naïve individuals continues. With varying international guidelines and evolving evidence, advising travellers requires detailed risk assessment, up-to-date evidence based decisions, and clear communication.
No takes yet. Share an insight, caveat, or question.
Fletcher et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: